![]() NKGen Biotech NKGen Biotech (formerly known as NKMax America) is a biotechnology company that develops cell therapies for neurodegenerative and oncological diseases based on activated NK cells. | ||
Founding Date | Founding Date 2017 | Founding Date 2017 |
Type | Type Subsidiary | Type Public |
Tags | ||
Locations | Locations HQ | Locations Santa Ana, US HQ |
Employees | Employees 3 | Employees 7316% increase |
Funding | ||
Total funding raised | Total funding raised $ 1m | Total funding raised $ 11m |

NKGen Biotech (formerly known as NKMax America) is a biotechnology company that develops cell therapies for neurodegenerative and oncological diseases based on activated NK cells.
View company